Clinical Trials Directory

Trials / Completed

CompletedNCT02062736

Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.

Studio Osservazionale Per Valutare l'Adeguatezza Del Dosaggio Del Metadone, Nelle Terapie di Mantenimento, in Rapporto Agli Obbiettivi di Outcome, in Pazienti Tossicodipendenti da Eroina. (METODO)

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study ( observational and prospective ) is to evaluate the efficacy and tolerability of the methadone maintenance treatment in patients addicted to heroin. The efficacy and tolerability are assessed by correlating to the adequacy of the dosage of methadone. The patients will be observed for two years.

Detailed description

500 patients will be selected among all patients addicted to heroin according to DSM-IV\_TR (Diagnostic and Statistical Manual of Mental Disorders IV\_ text revision), in maintenance methadone treatment, observed in the involved sites. The investigators will use treatment schemes with methadon conform to clinical practice and according to SPC (Summary of Product Characteristics). The enrollment will be competitive. Patients that meet incl/excl and that sign the informed consent, will be observed for 2 years. Follow up visits will be performed according to routine procedures, for patients that belong regularly to site at 3/6/9/12/18/24 months post V1. During the visits, patients will be assessed by validated and used as clinical practice questionnaires . For the evaluations of tolerability and safety the laboratory tests and electrocardiograms routinely performed will be collected.

Conditions

Timeline

Start date
2010-02-01
Primary completion
2014-02-01
Completion
2014-03-01
First posted
2014-02-14
Last updated
2016-04-28

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02062736. Inclusion in this directory is not an endorsement.